Department Of Physiology 2
51. Patterns of menstrual cycle, menstrual pain and medication usage in young women from high- and middle-income countries
52. Impact of virtual agent facial emotions and attention on N170 ERP amplitude: comparative study
53. Forecasting the Regional Demand for Medical Workers in Kazakhstan: The Functional Principal Component Analysis Approach
54. Study of chemical composition of extract from beta vulgaris seeds and its cytotoxic activity
55. Targeting Cbx3/HP1γ Induces LEF-1 and IL-21R to Promote Tumor-Infiltrating CD8 T-Cell Persistence
56. A Review of Botany, Phytochemistry, and Biological Activities of Eight Salvia Species Widespread in Kazakhstan
57. Salvia dumetorum essential oil: GC-MS analysis, antibacterial activity and effect on the formation of Streptococcus mutans biofilms
58. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
59. Role of c-miR-21, c-miR-126, Redox Status, and Inflammatory Conditions as Potential Predictors of Vascular Damage in T2DM Patients
60. Does COVID-19 contribute to development of neurological disease?
61. High-fat, western-style diet, systemic inflammation, and gut microbiota: A narrative review
62. Mitochondrial, metabolic and bioenergetic adaptations drive plasticity of colorectal cancer cells and shape their chemosensitivity
63. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
64. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
65. Identifying Key Biomarkers in Pediatric Pulmonary Hypertension: An Investigative Approach
66. Platelet-serotonin Dynamics: Elucidating Their Role in Pulmonary Arterial Hypertension
67. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
68. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
69. Domestic violence in Kazakhstan: Forensic-medical and medical-social aspects
70. Domestic violence in Kazakhstan: Forensic-medical and medical-social aspects
71. Forensic evaluation of craniometric characteristics of the Kazakhstan population
72. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
73. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
74. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
75. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
76. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
77. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
78. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
79. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
80. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
81. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
82. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
83. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
84. Synergistic Effects of Vitamin D and Exercise on Diabetes-induced Gonadotoxicity in Male Wistar Rats: Role of Xanthine Oxidase/Uric Acid and Nrf2/NfkB Signaling
85. Synergistic Effects of Vitamin D and Exercise on Diabetes-induced Gonadotoxicity in Male Wistar Rats: Role of Xanthine Oxidase/Uric Acid and Nrf2/NfkB Signaling
86. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
87. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
88. Correction of liver changes caused by alcohol rates with probiotics
89. Cytological Analysis of Upper Respiratory Tract Epithelial Cells in Chrysotile Asbestos Factory Workers
90. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
91. Nutritional status of healthcare professionals in primary health and social care
92. Parental Perceptions of Healthy Eating and Actual Nutrient Intake: Analysis of the Nutritional Status of Children Aged 1–6 Years in Urban Areas of Central Kazakhstan
93. Progressive endothelial coverage enhances hemocompatibility and prevents calcification in bioprosthetic valve tissue
94. Deformability of Heterogeneous Red Blood Cells in Aging and Related Pathologies
95. NEUROFEEDBACK SOFTWARE FOR NEUROSCIENCE RESEARCH IN THE BRAIN-TO-BRAIN SYNCHRONY
96. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
97. Biological (microfloral) factors of influence on cytogenetic stability during chemical mutagenesis
98. Lupane-Type Triterpenoids Biotransformation
99. Mapping routine measles vaccination in low- and middle-income countries
100. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
1 2 3